More than 20 years ago, Congress created the 340B Drug Pricing Program to allow eligible hospitals and health systems to stretch limited resources and expand access to care for vulnerable patients. But despite a proven track record of increasing patient access to vital medical services and decreasing government spending, some want changes that would weaken the program.   

340B hospitals continue to help care for low-income and uninsured patients. That is why the AHA sponsored today’s Capitol Hill briefing at which hospitals leaders shared examples of how their 340B programs help their patients and communities. Participating hospitals included Temple University Hospital in Philadelphia; Saint Thomas Health part of Ascension Health in Nashville, Tenn.; Trinity Health in Livonia, Mich.; and Providence Health & Services in Seattle. 

At the briefing, legislators and their staff heard how hospitals use the savings they receive from discounts on high prescription drug prices to reinvest in programs that enhance patient services and access to care.  

They heard how hospitals use 340B savings to provide local access to drugs and treatments for cancer patients, clinical pharmacy services, community outreach programs, free vaccinations, transportation to patients for follow-up appointments and many other services to their communities.   

In August, the Health Resources and Services Administration – the federal agency responsible for administering the 340B program – proposed new policies for the 340 program. Taken together, the changes could jeopardize eligible hospitals’ ability to care for vulnerable patients and communities. 

At the same time, the pharmaceutical industry and its supporters continue to make unsubstantiated claims about the program to persuade Congress to scale it back significantly.  

Hospital leaders are concerned that scaling back the 340B program would force hospitals to curtail or even eliminate services that are essential to keeping patients and communities healthy. Congress should heed the concerns of providers on the front lines of care – and toss aside the arguments of those who wish only to add to the record profits of pharmaceutical companies.

Watch our new video on why the 340B program is so important. And check out all of our 340B resources at www.aha.org/protect340B

Related News Articles

Headline
Continued rising drug prices, as well as shortages for many critical medications, are disrupting patient care and forcing hospitals to delay infrastructure and…
Headline
AHA said it generally supports CMS’ efforts to grant greater state-level flexibility and reduce regulatory burden, but urged the agency to ensure Medicaid…
Headline
Virginia hospitals and health systems provided nearly $3.3 billion in community benefit and other support in 2017, according to the latest annual report by the…
Perspective
We’re 11 days into 2019 … we’ve returned to a divided government …and the partial government shutdown continues.
Headline
The House of Representatives last night authorized its general counsel to intervene to defend the Affordable Care Act in a federal court case in Texas, and in…
Insights and Analysis
The secret to healthy, long lives lies in their social determinants. Six hospitals in a vulnerable area of Chicago pooled resources and ideas to address those…